Adaptimmune Therapeutics Plc (ADAPY)
0.0254
0.00 (0.00%)
USD |
OTCM |
Dec 29, 16:00
Adaptimmune Therapeutics EPS Diluted (Quarterly): -0.1163 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Autolus Therapeutics Plc | -0.2955 |
| NuCana Plc | -0.1348 |
| Mereo BioPharma Group Plc | -0.0436 |
| Bicycle Therapeutics Plc | -0.8476 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.70M |
| Revenue (Quarterly) | 13.84M |
| Total Expenses (Quarterly) | 44.54M |
| Enterprise Value | 29.34M |
| Gross Profit Margin (Quarterly) | 63.37% |
| Profit Margin (Quarterly) | -221.8% |
| Earnings Yield | -2.60K% |
| Normalized Earnings Yield | -2400.00 |